Ireland
--:--IST
Active, not recruiting Not applicable

Effect of Two Different Modes of Polarized Polychromatic Non-coherent Light Therapy on Jumper's Knee

NCT06306664 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2024-01-01
Last updated
2026-05-19

Condition(s) studied

Jumper's Knee

Investigational drug(s) / intervention(s)

BioptronPlacebo Comparator

Bioptron: Bioptron safely treats arthritis, neck \& back pain by stimulating blood circulation, reducing inflammation and relieving muscle spasms. For just ten minutes per day, our life-transforming technology offers the highest levels of pain relief by reaching deep into joints, muscles and ligaments.

Placebo Comparator: Patients will receive ice application+Exercises program designed for jumper knee

Study summary

The purposes of this study are:

1. To examine the combined effects of Yellow CPPNLT and conventional treatment on pain intensity, pain pressure threshold, functional disability, and muscle strength in athletic jumper knee.
2. To examine the combined effects of Green CPPNLT and conventional treatment on pain intensity, pain pressure threshold, functional disability, and muscle strength in athletic jumper knee.

3 3- To compare between the effects of Yellow CPPNLT and Green CPPNLT on pain intensity, pain pressure threshold, functional disability, and muscle strength in athletic jumper knee.

Eligibility

Sex
ALL
Min age
15 Years
Max age
35 Years
Healthy volunteers
Accepted
Inclusion Criteria: * History of Patellar tendinitis and anterior knee pain. * Age will be ranged from 15 to 35 years. * Both genders. * The onset of pain for over 3 months. Exclusion Criteria: * Knee surgery within the previous 6 months. * Chronic joint diseases. * Corticosteroid injection in the patellar tendon within the previous 3 months. * Use of drugs 48 hours previously (e.g., NSAIDs). * Any other concomitant treatment for PT.

Primary outcome measure(s)

  • Pain (Visual analogue scale). — Visual analogue scale will be investigated at baseline and after the treatment period of 4 weeks.
    The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. The VAS score for grading of pain consists of a 10 centimeters (cm) line with 10 mm (0.01 cm) to each point of the scale and two end-points representing no pain and worst possible pain.
  • pain intensity (Pressure algometry) — Pressure algometry will be investigated at baseline and after the treatment period of 4 weeks.
    Pressure pain threshold will be measured with algometry test FPX25 using 1-cm2 rubber tip on the knee extensors.10, 11 pressures will be applied slowly until the participant first feels the pain and response by saying stop there.
  • Disability questionnaire (Victorian institute of sport assessment-patella). — The VISA-P questionnaire will be investigated at baseline and after the treatment period of 4 weeks.
    The VISA-P, formerly known as the Victorian institute of sport assessment -patella Questionnaire, The VISA-P is questionnaire that assesses symptoms, simple tests of function, and the ability to play sports.
  • Muscle strength (Lafayette Hand held dynamometer) — The Lafayette hand held dynamometer will be investigated at baseline and after the treatment period of 4 weeks.
    The subjects will be positioned in sitting on chair and we will apply resistance when performing the dynamometer on patients and they will try to make maximal effort against resistance and we will record the change of length or resistance.

Trial sites (1)

FacilityCityRegionStatus
Physical Therapy Giza Dokki
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06306664 on ClinicalTrials.gov ↗ ← All trials in Egypt